Christer Malm, Iryna Yakovenko, Manoj Kumar Mandal and Håkan Hedman have been granted funding through the UBI call. Three researchers at Umeå University and one at the Swedish University of Agricultural Sciences (SLU) have been granted funding through Umeå Biotech Incubator’s (UBI) call “Pre‑Incubator Funding for Critical Experiments in Life Science.” The program targets researchers preparing to conduct decisive experiments that can validate or de‑risk early-stage innovation projects.
Among the selected projects are new approaches to preventing viral infections, improved detection of blood manipulation, and new treatment strategies for ovarian cancer.
The funding initiative is designed to enable critical experiments that are essential for the continued development of research-based innovations within life science.
SEK 970,000 in total
Each researcher has been awarded up to SEK 300,000 to cover costs associated with conducting their experiments. In total, SEK 970,000 has been distributed among four researchers: Christer Malm, Håkan Hedman, and Iryna Yakovenko from Umeå University, and Manoj Kumar Mandal from SLU and Umeå Plant Science Center.
”We received many high-quality applications. This demonstrates both that Umeå has a strong research environment within life science and that there is a clear ambition to translate research into societal benefit,” says Pia Keyser, Business Coach at Umeå Biotech Incubator.
“The projects we have funded combine high potential with being perfectly positioned for our ‘killer experiment’ call. At the same time, we will follow the progress of the other projects closely, and one or several of them may be suitable for a future UBI application,” she adds.
The following researchers have been awarded funding:
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Powered by Notified